[Nature] Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial |
|
This post will be closed automatically in 2026-10-31 10:17
Reward10points
|
10
Hydrogel for sustained and localized delivery of a regulatory T cell-inducing agent promotes bone regeneration
10
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial
10
https://www.nature.com/articles/s41562-026-02539-9
10
Enzymatic installation of post-translational modifications into artificial peptides using RiPP biosynthetic machinery
10
Merits, limitations and innovation priorities for heterogeneous catalytic platforms to destroy PFAS
